Niza Samsuddin 1, KG Rampal 2, Noor Hassim Ismail 3, Nur Zamzila Abdullah 4, Jamalludin Ab Rahman 1

Size: px
Start display at page:

Download "Niza Samsuddin 1, KG Rampal 2, Noor Hassim Ismail 3, Nur Zamzila Abdullah 4, Jamalludin Ab Rahman 1"

Transcription

1 Niza Samsuddin 1, KG Rampal 2, Noor Hassim Ismail 3, Nur Zamzila Abdullah 4, Jamalludin Ab Rahman 1 Department of Community Medicine, International Islamic University Malaysia 1 Perdana University School Graduate of Medicine 2 Department of Community Health, National University Malaysia 3 Department of Basic Medical Sciences, International Islamic University Malaysia 4

2 Health Effects of Organophosphates (OP) Pesticides : Cholinergic Syndrome, Intermediate Syndrome, COIDP, Neurobehavioural, Psychiatric changes Growing evidence that OP pesticides exposure possibly pose a greater risk of atherosclerosis: OPs exposure Low PON1 activity level among OPs exposed workers (Sozmen et.al, 2002; Hernandez et. al., 2003; Mackness et al.,2000). High oxidized-ldl in animal study

3 OPs Metabolism and Toxicity O R-O R-O P OH + OH-AChE R-O R-O O P O X + OH- AChE phosphorilated AChE R-O 1 R-O - O R-O O P O P O O 2 3 spontaneous reactivation of AChE AChE AChE + X negatively charge phosphorilated AChE + R

4 OPs Metabolism and Toxicity O R O P O X R O In animal tissues (Abraham Mazur 1946) Human and mammalian sera (Aldriedge 1953) Human study detoxifying process(li et al. 1995; Davies et. al., 1996, Mackness et. al., 2003; Costa et. al., 2003), limits toxicity OP (Himbergen et. al., 2004, James, 2006)

5 LOW PON1 ENZYMES PROMOTE OXIDATIVE MODIFICATION PON1 hydrolyze and decrease lipid peroxides (Mackness, 1991) PON1 prevent oxidative modification of LDL (Mackness & Durrington, 1995; Wilkins & Leake 1994,) PON1 deficient mice high oxidized-ldl (Shih et al, 1998) PON1 LIPID Lipid peroxidation (Oxidized-LDL)

6 ATHEROSCLEROSIS FORMATION Lipid peroxidation and inflammatory reaction in the vascular wall is the hypothesis of atherosclerosis formation. PON1 LIPID Lipid peroxidation (Oxidized-LDL) Oxidized-LDL stimulate the inflammatory changes in the endothelial vascular Inflammatory response of vascular wall Atherosclerosis

7 CONCEPTUAL FRAMEWORK LDL OP Pesticide exposure PON1 Oxidized-LDL CHE Inflammatory response of vascular wall Atherosclerosis Arterial segment stiffness Changes in CVS haemodynamic parameters SyphgmoCor System:

8 Genetic factors PON1 Lipid (LDL) Genetic factors Many established risk factors of atherosclerosis Age Sex BMI Oxidized-LDL Inflammatory response of vascular wall Atherosclerosis Obesity Hypertension Diabetes Smoking Infection Family history of CVDs MOA induces different cell activation (Alexander, 1995, Basta et al 2004;Kaori Fukuhama-Takaki, 2005) inflammatory process atherosclerosis (Libby P, 2002)

9 RESEARCH QUESTION Does OP pesticides exposed group of workers has the difference in cardiovascular haemodynamic parameters compared to nonexposed group of workers? RESEARCH HYPOTHESIS OP pesticides exposed group of workers is difference in terms of cardiovascular haemodynamic parameters compared to nonexposed group of workers.

10 RESEARCH OBJECTIVES General Objective: To establish whether OP pesticides exposed group of workers is difference in terms of cardiovascular haemodynamic parameters compared to non-exposed group of workers. Specific objective 1. To measure plasma pseudo-che activity level among OPs pesticide exposed and non-exposed group of workers the 2. To measure and compare CVS Haemodynamic parameters among OPs pesticide exposed and non-exposed group of workers namely: Peripheral Parameters - Brachial Blood Pressure - Mean Pulse Pressure - Pulse Pressure Central Parameters -Aortic Blood Pressure -Central Blood Pressure -Augmentation Pressure -Augmentation Index -Pulse Wave Velocity

11 Study design: cross sectional study (comparative study) Target population: The target population was workers who were exposed to OPs pesticide. Study population: The study population was the male vector unit, MOH workers who were exposed to OPs pesticide. Comparative population: Non-exposed pesticides workers that match to the study group in terms of age, sex, and income bracket. Sampling technique: Purposive sampling Calculated sample size: 400 (200 in each group)

12 Inclusion criteria: OP pesticides must be the main chemicals used in the spraying preparation. Working as pesticide sprayers for more than 1.5 years (Quinn, 2005; Terry et al 2007) Age between 20 to 55 years old (CPG, 2004)

13 Exclusion criteria Tachycardia (Heart more than 100 bpm) Irregular rhythm (Ectopic beats, drop beats) Smoking or drinking caffeinated drinks 4 hrs before the 2 nd appointment for CVS assessment.

14 SYPHGMOCOR

15 By measuring radial pulse wave the general transfer function in the system will extrapolate the aortic pulse wave and pressure and later the central CVS haemodynamic parameters.

16 PWV values derived from carotid-femoral measurements (Im J-A, Lee J-W et al. 2007). Each detects the onset of the pressure wave form, in relation to an electrocardiogram time point. The distance along the arterial tree is measured and the velocity is calculated

17 Portable, convenient for screening Good inter and intra-operator reproducibility (Wilkinson et al 1998, Liang YL et al, 1998) Minimum training (Davies and Struthers, 2003) Powerful diagnostic instrument (Orlova et al 2008) High positive and negative predictive values (Benczur et al 2007, Davies and Struthers, 2003)

18 RESULTS 345 workers handling OP pesticides at work, identified in selected district health departments. 119 workers were excluded from the study 226 workers were included in the study 9- female workers 27- no exposure 20- age more than exposed less than 1.5 years 16 workers refused to participate 210 workers gave written consent to participate and gave blood samples

19 210 workers gave written consent to participate and gave blood samples 15 workers failed to attend SyphmoCor test (Nonrespond) 195 had undergone SypgmoCor test 3 workers failed to come for blood sample collection 6 had abnormal heart rhythm and 3 failed to get acceptable quality of report 186 data on PWA were acceptable for data analyses Pulse Wave Velocity Another 6 failed to get acceptable quality of PWV report, 180 data on PWV were acceptable for data analyses

20 NON-EXPOSED GROUP 200 workers that meet inclusion criteria were identified and gave their written consent 186 workers attended SyphmoCor test (14-Nonresponded) 2 had abnormal heart rhythm 5 workers failed to come for blood sample collection Pulse Wave Analyses Pulse Wave Velocity 14 failed to get acceptable quality of report, 184 data on PWA were acceptable for data analyses Another 16 failed to get acceptable quality of report, 168 data on PWV were acceptable for data analyses

21 Exposed group Non-exposed group Study place N(%) Study place N(%) DHO, Hulu Terengganu 15(8.1) JKR Kuantan 35(19.0) DHO, Kuala Terengganu 20(10.8) JKR Pekan 42(22.8) DHO, Besut 19(10.2) IIUM 26(14.1) DHO, Setiu 14(7.5) Kuantan Local Authority 81(44.0) DHO, Dungun 15(8.1) DHO, Kemaman 13(7.0) DHO, Kuantan 51(27.4) DHO, Pekan 28(15.1) DHO, Maran 11(5.9) Total 186(100) 184(100) DHO= District Health Office

22 Exposed group Non-exposed group N(%) N(%) General worker 74(9.8) 61(33.2) Public health assistant 62(33.3) 4(2.2) Driver 41(22.0) 54(29.3) Environmental health officer 9(4.8) 2(1.1) Technician - 28(15.2) Mechanic - 5(2.7) Security - 6(3.3) Office worker - 8(4.3) Enforcement officer - 16(8.7) Total 186(100) 184(100)

23 Exposed group N(%) Non-exposed group N(%) P value Age (year) 38±8 42±9 <0.001* Income(RM) ± ± <0.001* Education level Primary 20(10.8) 20(10.4) Secondary 157(84.4) 143(77.7) Tertiary 9(4.8) 21(11.4) Smoking Never 72(38.7) 81(44.0) Current 93(50.0) 76(41.3) Former 21(11.3) 27(14.7)

24 Exposed group (n=186) Non-exposed group (n=184) P value Weight(kg) 69.9± ± * Height(m) 166.5± ± BMI(kg/m 2 ) 25.2± ±5.1 <0.001* Family history of sudden death or heart attack Current Health Problems 16(8.6) 20(8.9) Diabetes Mellitus 9(4.8) 13(7.1) Hypertension 19(10.2) 25(13.6) Heart disease 2(1.1) 3(1.6) Kidney disease 4(2.2) 0(0) 0.045* Respiratory disease 11(5.9) 15(8.2) 0.40 Pseudo-cholinesterase (U/L) ± ±

25 Environmental Health Officer N=9 Driver N=41 Public Health Assistant N=62 General Worker N=74 P value Age(year) 36±6 40±8 40±8 36± * Salary(RM) ± ± ± ± <0.001* Education Primary 0(0) 7(17.1) 0(0) 13(17.6) 0.008* Secondary 1(11.1) 34(82.9) 61(98.4) 61(82.4) Tertiary 8(88.9) 0(0) 1(1.6) 0(0) Smoking Never 3(33.3) 15(36.6) 26(41.9) 28(37.8) Current 4(44.4) 20(48.8) 28(45.2) 41(55.4) Former 2(22.2) 6(14.6) 8(12.9) 5(6.8) Statistical test: one way of anova EHO is excluded from the statistical analysis due to small number of respondent in the group

26 Environmental Health Officer N=9 Driver N=41 Public Health Assistant N=62 General Worker N=74 P value Weight(kg) 71.7± ± ± ± * Height(m) 165.9± ± ± ± BMI(kg/m 2 ) 25.8± ± ± ± * FH of sudden death or 1(11.1) 5(12.2) 7(11.3) 3(4.1) heart attack Current Health Problems Diabetes Mellitus 0(0) 3(7.3) 3(4.8) 3(4.1) Hypertension 1(11.1) 6(14.6) 8(12.9) 4(5.4) Heart disease 1(11.1) 0(0) 1(1.6) 0(0) Kidney disease 0(0) 1(2.4) 1(1.6) 2(2.7) Respiratory disease 1(11.1) 4(9.8) 4(6.5) 2(2.7) Pseudo-cholinesterase (U/L) ± ± ± ± Statistical test: one way anova EHO is excluded from the statistical analysis due to small number of respondent in the group

27 EHO N=9 N(%) Driver N=41 N(%) PHA N=62 N(%) Gen.Worker N=74 N(%) P value Duration of working (months) 85.6± ± ± ±56.8 <0.001* Duration of working (day/week) 2.6± ± ± ± Duration of working (hour/day) 2.22± ± ± ± Had training on chemical 8(88.9) 18(43.9) 55(88.7) 63(85.1) <0.001* handling technique Had training on PPE 8(88.9) 7(17.1) 53(85.5) 57(77.0) <0.001* Used of PPE Goggle 3(33.3) 12(29.3) 33(53.2) 59(79.7) <0.001* Respirator 7(77.8) 30(73.2) 60(96.8) 72(97.3) <0.001* Plastic gloves 2(22.2) 13(31.7) 38(61.3) 58(78.4) <0.001* Plastic apron 1(11.1) 7(17.1) 10(16.1) 23(31.1) Safety boot 6(66.7) 28(68.3) 49(79.0) 65(87.8) 0.040* Ear plug 5(55.6) 17(41.5) 56(90.3) 71(95.9) <0.001* Statistical test: one way of anova EHO is excluded from the statistical analysis due to small number of respondent in the group

28 Exposed group Non-exposed P value N=186 group N=184 Heart Rate (bpm) 70±13 66± * Brachial Systolic BP (mmhg) 124±19 122± Brachial Diastolic BP (mmhg) 79±14 75± * Brachial Pulse Pressure (mmhg) 46±10 48± Peripheral Pulse Pressure (mmhg) 94±15 91± Aortic Systolic BP (mmhg) 112±16 111± Aortic Diastolic BP (mmhg) 79±15 76± * Central Pulse Pressure (mmhg) 32.17± ± * Aortic Augmentation Pressure (mmhg) 6.08± ± * Aortic Augmentation Index 15.46± ± Pulse Wave Velocity (m/s) 7.08± ± Statistical test: independent t-test Significant level at p=0.05

29 Group Age BMI Effect size p value Effect size p value Effect size p value Heart rate (b/m) <0.001* <0.001* Brachial SBP * <0.001* <0.001* (mmhg) Brachial DBP 0.07 <0.001* <0.001* <0.001* (mmhg) Mean PP (mmhg) <0.001* <0.001* <0.001* PPP (mmhg) * * Aortic SBP * <0.001* <0.001* (mmhg) Aortic DBP <0.001* <0.001* <0.001* (mmhg) CPP (mmhg) <0.001* AP (mmhg) <0.001* * AIx (%) * <0.001* PWV(m/s) < <0.001* Effect size is determine by partial eta 2

30 EHO N=9 Driver N=41 PHA N=62 Gen.Worker N=74 Heart Rate (bpm) 66±10 71±12 70±14 70± P value Brachial SBP (mmhg) 121±9 133±22 123±14 120±16 <0.001* Brachial DBP (mmhg) 76±4 84±17 78±11 76± * Brachial Mean PP (mmhg) 91±6 100±21 94±11 91± * Peripheral PP (mmhg) 45±9 51±12 45±10 44± * Aortic SBP (mmhg) 108±10 121±21 111±13 108±15 <0.001* Aortic DBP (mmhg) 77±4 85±17 77±16 77± * CPP (mmhg) 30±8 35±9 32±8 31± * AP (mmhg) 4.56± ± ± ± Aix (%) 10.22± ± ± ± PWV (m/s) 7.46± ± ± ± Statistical test: one way anova EHO is excluded from the statistical analysis due to small number of respondent in the group

31 Group Age BMI Effect size p value Effect size p value Effect size p value Heart rate (b/m) <0.001* Brachial SBP (mmhg) * <0.001* <0.001* Brachial DBP (mmhg) * <0.001* Mean PP (mmhg) * <0.001* PPP (mmhg) * * * Aortic SBP (mmhg) * <0.001* <0.001* Aortic DBP (mmhg) * <0.001* CPP (mmhg) * <0.001* AP (mmhg) <0.001* * AIx (%) <0.001* PWV(m/s) <0.001 * <0.001* Effect size is determined by partial eta 2

32 Failed to show depressed pseudo-che activity level Some other research findings showed significantly lower plasma CHE levels among the pesticide exposed group [Clerk E.E.K et al 1997, Ciesielski et. Al 1994, Sirivarasai J. et. Al. 2007] but some failed to establish the significant difference between the pesticides exposed and non-exposed group [Inayat-Hussain, 2007]. The possible reasons for inconsistent findings were different degree of pesticides exposure, body adaptation in producing more CHE in chronic exposure [Hayes W. J. 1982]

33 This study showed statistically higher heart rate, brachial BP, mean Arterial Pressure, Aortic BP and AIx among the OP pesticides exposed workers compared with the non-exposed group of workers, however the effect size is small. Higher brachial BP is associated with higher risk of cardiovascular disease (Lewington S., Clarke R. et al, 2002, Mac Mohan S, Peto R, 1990) Mean and Pulse Pressure are predictors of cardiovascular disease (Franklin SS, Lopez VA, 2009) Aortic BP has been shown to be an independent predictor of incident cardiovascular disease, independent of brachial systolic blood pressure (Roman, Kizer JR et al. 2005). The AIx has also been shown to be independently correlates with the extent of coronary artery disease (Weber T, Auer J et al. 2004), maximal aortic intima-media thickness (Qureshi G, Brown R et al. 2007), cardiovascular risk (Nürnberger J, Keflioglu-Scheiber A et al. 2002) and all-cause mortality (London GM, Blacher J et al. 2001).

34 The drivers were having higher BMI and had poor pesticides handling practices compared with the General Workers and PHA. Being the driver they had significant increase in terms of brachial and systolic blood pressure, pulse pressure and central BP. However the effect size is small. The obvious findings were age gives significant and strong effects in the changes of Central Pulse Pressure, AIx and PWV BMI gives significant and strong effects in the changes of PWV

35 The study concluded that OP pesticides exposure may contribute to the increase in cardiovascular risk through the changes in CVS haemodynamic parameters. Future study should explore on The genetic and phenotype of PON1 among the OP pesticides exposed workers in association with CVS haemodynamic parameters.

36 Express of thank you to: Director General of Ministry of Health IIUM and PPUKM Staff of Department of Community Health, HUKM Staff of Department of Community Medicine, IIUM and Kulliyyah of Medicine Research assistants

Endothelial function is impaired in women who had pre-eclampsia

Endothelial function is impaired in women who had pre-eclampsia Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity

Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity Clinical application of Arterial stiffness pulse wave analysis pulse wave velocity Arterial system 1. Large arteries: elastic arteries Aorta, carotid, iliac, Buffering reserve: store blood during systole

More information

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs

More information

Coronary artery disease (CAD) risk factors

Coronary artery disease (CAD) risk factors Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes

More information

HTA ET DIALYSE DR ALAIN GUERIN

HTA ET DIALYSE DR ALAIN GUERIN HTA ET DIALYSE DR ALAIN GUERIN Cardiovascular Disease Mortality General Population vs ESRD Dialysis Patients 100 Annual CVD Mortality (%) 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age

More information

A Comparative Study of Methods of Measurement of Peripheral Pulse Waveform

A Comparative Study of Methods of Measurement of Peripheral Pulse Waveform 2009. Vol.30. No.3. 98-105 The Journal of Korean Oriental Medicine Original Article A Comparative Study of Methods of Measurement of Peripheral Pulse Waveform Hee-Jung Kang 1, Yong-Heum Lee 2, Kyung-Chul

More information

Managing cardiovascular risk with SphygmoCor XCEL

Managing cardiovascular risk with SphygmoCor XCEL Managing cardiovascular risk with SphygmoCor XCEL Central pulse pressure better predicts outcome than does brachial pressure Roman et al., Hypertension, 2007; 50:197-203 Carotid to femoral Pulse Wave Velocity

More information

Arterial Age and Shift Work

Arterial Age and Shift Work 340 Arterial Age and Shift Work Ioana Mozos 1*, Liliana Filimon 2 1 Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania 2 Department of Occupational

More information

Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece

Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece ARGYRIS Vassilis, PEROULIS Michalis, MATSAGKAS Miltiadis, BECHLIOULIS Aris, MICHALIS Lampros, NAKA

More information

Central Pressures and Prehypertension

Central Pressures and Prehypertension Central Pressures and Prehypertension Charalambos Vlachopoulos Associate Professor of Cardiology 1 st Cardiology Dept Athens Medical School Central Pressures and Prehypertension Charalambos Vlachopoulos

More information

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure

Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure 801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem

More information

Arterial Pressure in CKD5 - ESRD Population Gérard M. London

Arterial Pressure in CKD5 - ESRD Population Gérard M. London Arterial Pressure in CKD5 - ESRD Population Gérard M. London INSERM U970 Paris 150 SBP & DBP by Age, Ethnicity &Gender (US Population Age 18 Years, NHANES III) 150 SBP (mm Hg) 130 110 80 Non-Hispanic Black

More information

Pesticide Exposure and Cardiovascular Hemodynamic Parameters Among Male Workers Involved in Mosquito Control in East Coast of Malaysia

Pesticide Exposure and Cardiovascular Hemodynamic Parameters Among Male Workers Involved in Mosquito Control in East Coast of Malaysia Original Article Pesticide Exposure and Cardiovascular Hemodynamic Parameters Among Male Workers Involved in Mosquito Control in East Coast of Malaysia Niza Samsuddin, 1 Krishna Gopal Rampal, 2 Noor Hassim

More information

Effects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France

Effects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France Effects of Renin-Angiotensin System blockade on arterial stiffness and function Gérard M. LONDON Manhès Hospital Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호

Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호 Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호 Arterial stiffness Arterial stiffness is inversely related to arterial

More information

Arterial function and longevity Focus on the aorta

Arterial function and longevity Focus on the aorta Arterial function and longevity Focus on the aorta Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Secrets of longevity Secrets of longevity Unveiling

More information

Measurement of Arterial Stiffness: Why should I measure both PWA and PWV?

Measurement of Arterial Stiffness: Why should I measure both PWA and PWV? Measurement of Arterial Stiffness: Why should I measure both PWA and PWV? Central blood pressure and measures of arterial stiffness have been shown to be powerful predictors of major cardiovascular events,

More information

Background. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C.

Background. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C. The effect of metabolic syndrome for left ventricular geometry, arterial stiffness and carotid intima-media thickness in Korean general population Result from Atherosclerosis RIsk of Rural Area in Korea

More information

Managing anti-hypertensive treatment with SphygmoCor XCEL

Managing anti-hypertensive treatment with SphygmoCor XCEL Managing anti-hypertensive treatment with SphygmoCor XCEL Measurement of Central aortic BP may provide valuable information on antihypertensive drug action that is not apparent with assessment of Brachial

More information

TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients

TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients CARDIOVASCULAR TECHNOLOGY AND INDICATION SERVICE TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients SERIES Hypertension Management in the

More information

Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease

Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease Michelle P Kao, Donald S Ang, Steve Gandy, Chim C Lang, Allan D Struthers Division of

More information

Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις

Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις Ελένη Τριανταφυλλίδη Επιμελήτρια Α Β Πανεπιστημιακή Καρδιολογική Κλινική Αττικό Νοσοκομείο

More information

Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski

Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly Piotr Jankowski I Department of Cardiology and Hypertension CM UJ, Kraków, Poland piotrjankowski@interia.pl Vienna,

More information

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France

Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France The causes of Cardiovascular Diseases in CKD Systolic BP;

More information

surtout qui n est PAS à risque?

surtout qui n est PAS à risque? 3*25 min et surtout qui n est PAS à risque? 2018 ESC/ESH Hypertension Guidelines 2018 ESC-ESH Guidelines for the Management of Arterial Hypertension 28 th ESH Meeting on Hypertension and Cardiovascular

More information

APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS

APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS APPLICATION OF PHYSICAL METHODS FOR DETERMINATION OF FUNCTIONAL PARAMETERS OF ARTERIES IN RHEUMATIC PATIENTS Jolanta DADONIENE*, Alma CYPIENE**, Diana KARPEC***, Rita RUGIENE*, Sigita STROPUVIENE*, Aleksandras

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu Indicator area: Pulse rhythm assessment for AF Indicator: NM146 Date: June 2017 Introduction There is evidence

More information

SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease

SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease FLAVIOLA Targeted delivery of dietary flavanols for optimal human cell function: Effects on cardiovascular health SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease Flavanol

More information

PHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT

PHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT PHENOTYPING FAMILIES OF A HYPERTENSIVE PATIENT Christian Delles BHF Glasgow Cardiovascular Research Centre Advantages Cardiovascular of a Family-based ContinuumDesign Related subjects are more likely to

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome

Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome 243 Original Article Hypertens Res Vol.30 (2007) No.3 p.243-247 Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome Yutaka KOJI

More information

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman

Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease Greg Wellenius Joel Kaufman Framework for Choosing Subclinical Outcomes To Study What clinical outcomes

More information

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step

More information

John Feely deceased. Received 21 October 2008 Revised 5 June 2009 Accepted 28 June 2009

John Feely deceased. Received 21 October 2008 Revised 5 June 2009 Accepted 28 June 2009 2186 Original article Assessment of arterial stiffness in hypertension: comparison of oscillometric (Arteriograph), piezoelectronic (Complior) and tonometric (SphygmoCor) techniques M Noor A. Jatoi, Azra

More information

When should you treat blood pressure in the young?

When should you treat blood pressure in the young? ESC Stockholm - Dilemmas in Cardiovascular Disease Prevention in the Young: 30 th August 2010 When should you treat blood pressure in the young? Bryan Williams MD FRCP FAHA FESC Professor of Medicine Department

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction

Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction Central hemodynamics and prediction of cardiovascular events in patients with erectile dysfunction N.Skliros, N.Ioakeimidis, D.Terentes-Printzios, C.Vlachopoulos Cardiovascular Diseases and Sexual Health

More information

Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση

Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση Πρώιμη αγγειακή γήρανση στην υπέρταση: διάγνωση και αντιμετώπιση Χαράλαμπος Βλαχόπουλος 1 η Καρδιολογική Κλινική Πανεπιστημίου Αθηνών Ιπποκράτειο Γ.Ν.Α. Οι προβλεπόμενες αρτηριακές αλλαγές με βάση την

More information

A Comparative Study of Physical Fitness among Rural Farmers and Urban Sedentary Group of Gulbarga District

A Comparative Study of Physical Fitness among Rural Farmers and Urban Sedentary Group of Gulbarga District AJMS Al Ameen J Med Sci (20 1 2 )5 (1 ):3 9-4 4 (A US National Library of Medicine enlisted journal) I S S N 0 9 7 4-1 1 4 3 C O D E N : A A J M B G ORIGI NAL ARTICLE A Comparative Study of Physical Fitness

More information

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS A.J. Scheen, J.C. Philips, M. Marchand Division of Diabetes, Nutrition

More information

Cardiovascular Diseases in CKD

Cardiovascular Diseases in CKD 1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

Cardiovascular disease and diabetes Vascular harmony

Cardiovascular disease and diabetes Vascular harmony Cardiovascular disease and diabetes 2018 Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics

More information

The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics and Arterial Stiffness of Patients with Isolated Systolic Hypertension

The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics and Arterial Stiffness of Patients with Isolated Systolic Hypertension Original ORIGINAL Article ARTICLE Korean Circulation J 2007;37:359-364 ISSN 1738-5520 c 2007, The Korean Society of Circulation The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics

More information

Early Detection of Damaged Organ

Early Detection of Damaged Organ Early Detection of Damaged Organ Regional Cardiovascular Center, Chungbuk National University Kyung-Kuk Hwang Contents NICE guideline 2011 - Confirm the diagnosis of HT ambulatory blood pressure monitoring

More information

Cigarette smoking is one of the most important avoidable

Cigarette smoking is one of the most important avoidable Arterial Stiffness Impact of Smoking and Smoking Cessation on Arterial Stiffness and Aortic Wave Reflection in Hypertension Noor A. Jatoi, Paula Jerrard-Dunne, John Feely, Azra Mahmud Abstract Cigarette

More information

Abstract nr AHA, Chicago November European Heart Journal Cardiovascular Imaging, in press. Nr Peter Blomstrand

Abstract nr AHA, Chicago November European Heart Journal Cardiovascular Imaging, in press. Nr Peter Blomstrand Left Ventricular Diastolic Function Assessed by Echocardiography and Tissue Doppler Imaging is a strong Predictor of Cardiovascular Events in Patients with Diabetes Mellitus Type 2 Peter Blomstrand, Martin

More information

Which CVS risk reduction strategy fits better to carotid US findings?

Which CVS risk reduction strategy fits better to carotid US findings? Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department

More information

INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING

INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS TELEMONITORING VASOTENS Registry Vascular health ASsessment Of The hypertensive patients Project Coordinator: Dr. Stefano Omboni

More information

Special Lecture 10/28/2012

Special Lecture 10/28/2012 Special Lecture 10/28/2012 HYPERTENSION Dr. HN Mayrovitz Special Lecture 10/28/2012 Arterial Blood Pressure (ABP) - Definitions ABP Review Indirect Oscillographic Method Resistance (R), Compliance (C)

More information

Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements

Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements Original Article J Clin Med Res. 2018;10(4):309-313 Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements Kannayiram Alagiakrishnan a, d, Ruojin

More information

Obstructive sleep apnea syndrome (OSAS) is a common

Obstructive sleep apnea syndrome (OSAS) is a common Impact of Obstructive Sleep Apnea Syndrome on Endothelial Function, Arterial Stiffening, and Serum Inflammatory Markers: An Updated Meta-analysis and Metaregression of 18 Studies Jiayang Wang, MD; Wenyuan

More information

Pulse wave velocity, augmentation index and arterial age in students

Pulse wave velocity, augmentation index and arterial age in students Pulse wave velocity, augmentation index and arterial age in students IOANA MOZOS 1, SERBAN GLIGOR 2 1 Department of Functional Sciences Victor Babes University of Medicine and Pharmacy Timisoara ROMANIA

More information

Florida State University Libraries

Florida State University Libraries Florida State University Libraries Honors Theses The Division of Undergraduate Studies 2014 The Effects of Oral L-Citrulline and Caffeine Supplementation on Arterial Function in Healthy Males Zachary Grunewald

More information

Fondazione C.N.R./Regione Toscana G. Monasterio Pisa - Italy. Imaging: tool or toy? Aortic Compliance

Fondazione C.N.R./Regione Toscana G. Monasterio Pisa - Italy. Imaging: tool or toy? Aortic Compliance Fondazione C.N.R./Regione Toscana G. Monasterio Pisa - Italy massimo lombardi Imaging: tool or toy? Aortic Compliance 2011 ESC Paris Disclosure: Cardiovascular MR Unit is receiving research fundings from

More information

Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo?

Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo? Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo? Prof. Massimo Salvetti Clinica Medica University of Brescia Percieved risk Actual risk Sehestedt et al,

More information

This Protocol is applicable to Class 1, 2, and Class 3 applicants. Resting ECG shall be performed at the following intervals:

This Protocol is applicable to Class 1, 2, and Class 3 applicants. Resting ECG shall be performed at the following intervals: SCHEDULE 34: PROTOCOL ON ELECTROCARDIOGRAMS ( ECG ) 1. Applicability This Protocol is applicable to Class 1, 2, and Class 3 applicants. 2. Resting ECG Resting ECG shall be perfmed at the following intervals:

More information

Chapter 08. Health Screening and Risk Classification

Chapter 08. Health Screening and Risk Classification Chapter 08 Health Screening and Risk Classification Preliminary Health Screening and Risk Classification Protocol: 1) Conduct a Preliminary Health Evaluation 2) Determine Health /Disease Risks 3) Determine

More information

Vital Signs. Vital Signs. Pulse. Temperature. Respiration. Blood Pressure

Vital Signs. Vital Signs. Pulse. Temperature. Respiration. Blood Pressure Vital Signs Jarvis, Chapter 9 Vital Signs Classic Vital Signs TPR/BP Temperature Pulse Respirations Blood Pressure Additional Vital Signs Height Weight BMI (Kg/m2) or (702Xlbs/in2) Supine, orthostatic

More information

Arterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension

Arterial stiffness index: A new evaluation for arterial stiffness in elderly patients with essential hypertension Blackwell Science, LtdOxford, UK GGIGeriatrics and Gerontology International1444-15862002 Blackwell Science Asia Pty Ltd 24December 2002 045 ASI in elderly hypertensive patients M Kaibe et al. 10.1046/j.1444-1586.2002.00045.x

More information

Peripheral Vessels Unit, 1st Department of Cardiology Athens Medical School Hippokration Hospital, Athens, Greece

Peripheral Vessels Unit, 1st Department of Cardiology Athens Medical School Hippokration Hospital, Athens, Greece Peripheral Vessels Unit, 1st Department of Cardiology Athens Medical School Hippokration Hospital, Athens, Greece Dimitrios Terentes-Printzios, Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Mahmoud Abdelrasoul,

More information

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION

ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,

More information

Cl inical Study of Arterial Buffering Function and Endothel ial Function in Patients with Essential Hypertension

Cl inical Study of Arterial Buffering Function and Endothel ial Function in Patients with Essential Hypertension 48 (200025) 54 16 ( Pulse wave velocity PWV) - PWV(CPWV) (Distensibility) (CSC) (VD) CPWV ( P = 0. 0483) CSC VD ( P = 0. 0302 P = 0. 0196) ( P = 0. 0130) VD ( r = 0. 3995 P = 0. 0011) Cl inical Study of

More information

Blood Pressure Response Under Chronic Antihypertensive Drug Therapy

Blood Pressure Response Under Chronic Antihypertensive Drug Therapy Journal of the American College of Cardiology Vol. 53, No. 5, 29 29 by the American College of Cardiology Foundation ISSN 735-197/9/$36. Published by Elsevier Inc. doi:1.116/j.jacc.28.9.46 Hypertension

More information

Arterial Stiffness: pathophysiology and clinical impact. Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France

Arterial Stiffness: pathophysiology and clinical impact. Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France Arterial Stiffness: pathophysiology and clinical impact Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance Arterial

More information

3 Aging, Arterial Stiffness,

3 Aging, Arterial Stiffness, Chapter 3 / Mechanisms of Hypertension 23 3 Aging, Arterial Stiffness, and Systolic Hypertension Joseph L. Izzo, Jr., MD CONTENTS INTRODUCTION POPULATION STUDIES PATHOPHYSIOLOGY NONINVASIVE MEASUREMENT

More information

Η ΣΗΜΑΣΙΑ ΤΗΣ ΜΕΛΕΤΗΣ ΤΟΥ ΕΝΔΟΘΗΛΙΑΚΟΥ ΓΛΥΚΟΚΑΛΥΚΑ ΣΤΙΣ ΚΑΡΔΙΑΓΓΕΙΑΚΕΣ ΠΑΘΗΣΕΙΣ

Η ΣΗΜΑΣΙΑ ΤΗΣ ΜΕΛΕΤΗΣ ΤΟΥ ΕΝΔΟΘΗΛΙΑΚΟΥ ΓΛΥΚΟΚΑΛΥΚΑ ΣΤΙΣ ΚΑΡΔΙΑΓΓΕΙΑΚΕΣ ΠΑΘΗΣΕΙΣ Η ΣΗΜΑΣΙΑ ΤΗΣ ΜΕΛΕΤΗΣ ΤΟΥ ΕΝΔΟΘΗΛΙΑΚΟΥ ΓΛΥΚΟΚΑΛΥΚΑ ΣΤΙΣ ΚΑΡΔΙΑΓΓΕΙΑΚΕΣ ΠΑΘΗΣΕΙΣ ΙΓΝΑΤΙΟΣ(ΟΙΚΟΝΟΜΙΔΗΣ ΕΠΙΚΟΥΡΟΣ(ΚΑΘΗΓΗΤΗΣ(ΚΑΡΔΙΟΛΟΓΙΑΣ Β (ΠΑΝΕΠΙΣΤΗΜΙΑΚΗ(ΚΑΡΔΙΟΛΟΓΙΚΗ(ΚΛΙΝΙΚΗ(ΕΚΠΑ ΝΟΣΟΚΟΜΕΙΟ(ΑΤΤΙΚΟΝ Endothelial+Glycocalyx

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Aortic backward waves derived from wave separation analysis, and end-organ changes.

Aortic backward waves derived from wave separation analysis, and end-organ changes. Aortic backward waves derived from wave separation analysis, and end-organ changes. Imraan Ballim Dissertation submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,

More information

Pathophysiology of Vascular Function in CKD. INSERM U970 Hôpital Européen Georges Pompidou Paris

Pathophysiology of Vascular Function in CKD. INSERM U970 Hôpital Européen Georges Pompidou Paris Pathophysiology of Vascular Function in CKD Gérard M. London INSERM U970 Hôpital Européen Georges Pompidou Paris Arterial Pathophysiology and Cardiovascular Diseases in CKD Systolic BP; Diastolic BP Arteriosclerosis

More information

Aortic Augmentation Index in Patients With Peripheral Arterial Disease

Aortic Augmentation Index in Patients With Peripheral Arterial Disease ORIGINAL PAPER Aortic Augmentation Index in Patients With Peripheral Arterial Disease Mariella Catalano, MD; 1 Giovanni Scandale, MD; 1 Gianni Carzaniga; 1 Michela Cinquini, BSc; 2 Marzio Minola, MD; 1

More information

The importance of arterial blood pressure (BP) as a

The importance of arterial blood pressure (BP) as a AJH 2005; 18:1463 1467 Pulse Pressure Predicts Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus John R. Cockcroft, Ian B. Wilkinson, Marc Evans, Philip McEwan, John R. Peters, Steve Davies,

More information

ARTERIAL STIFFNESS ASSESSMENT COMMENTS:

ARTERIAL STIFFNESS ASSESSMENT COMMENTS: ARTERIAL STIFFNESS ASSESSMENT 10% Low small artery stiffness risk. However, we detect mild vasoconstriction in small artery. No large arterial stiffness has been detected. High Blood Pressure & Arterial

More information

Clinical Care Performance. Financial Year 2012 to 2018

Clinical Care Performance. Financial Year 2012 to 2018 Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c

More information

Introduction of diverse devices to measure arterial stiffness

Introduction of diverse devices to measure arterial stiffness Slide 1 Introduction of diverse devices to measure arterial stiffness PARK, Jeong Bae, MD, PhD, Medicine/Cardiology, Samsung Cheil Hospital, Sungkyunkwan University School of Medicine 2005 5 27 일혈관연구회부산집담회,

More information

Preventing Early Vascular Ageing (EVA) and its hemodynamic changes

Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Translational Research 31 st October 2013, Moscow Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Peter M Nilsson, MD, PhD Department of Clinical Sciences Lund University University

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

Beyond Framingham. Prediction of cardiovascular risk. Niels van Pelt Cardiologist, Middlemore Hospital

Beyond Framingham. Prediction of cardiovascular risk. Niels van Pelt Cardiologist, Middlemore Hospital Beyond Framingham Prediction of cardiovascular risk Niels van Pelt Cardiologist, Middlemore Hospital Niels Bohr (Danish Physicist)1885-1962 Prediction is very difficult, especially if it's about the future

More information

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS? HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL

More information

EXS 145 Guidelines for Exercise Testing & Prescription

EXS 145 Guidelines for Exercise Testing & Prescription EXS 145 Guidelines for Exercise Testing & Prescription 11-3-11 Andrew Weiler M.Ed MCCD Adjunct Faculty CGCC Employee Wellness Coordinator SRPMIC Employee Wellness Coordinator Pot & Window LLC Today How

More information

pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension

pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension Supplementary material Jonas K, Magoń W, Waligóra M, et al. High density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension Pol

More information

Impact of Aortic Stiffness on Further Cardiovascular Events in Patients with Chest Pain : A Invasive Study

Impact of Aortic Stiffness on Further Cardiovascular Events in Patients with Chest Pain : A Invasive Study Impact of Aortic Stiffness on Further Cardiovascular Events in Patients with Chest Pain : A Invasive Study Cheol Ung Choi, Chang Gyu Park, Eun Bum Park, Soon Yong Suh, Jin Won Kim, Eung Ju Kim, Seung-

More information

Research Article The Age-Dependent Contribution of Aortic Incident and Reflected Pressure Waves to Central Blood Pressure in African-Americans

Research Article The Age-Dependent Contribution of Aortic Incident and Reflected Pressure Waves to Central Blood Pressure in African-Americans SAGE-Hindawi Access to Research International Hypertension Volume 211, Article ID 58573, 6 pages doi:1.461/211/58573 Research Article The Age-Dependent Contribution of Aortic Incident and Reflected Pressure

More information

Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation

Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation 14/9/2018 Importance of changes in thoracic and abdominal aortic stiffness following stent graft implantation Christos D. Liapis, MD, FACS, FRCS, FEBVS Professor (Em) of Vascular Surgery National & Kapodistrian

More information

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016 The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief

More information

BLOOD PRESSURE. Unit 3: Transportation and Respiration

BLOOD PRESSURE. Unit 3: Transportation and Respiration BLOOD PRESSURE Unit 3: Transportation and Respiration Blood Pressure The force of your blood pushing on the walls of your arteries. How is Blood Pressure Measured? Measured at an artery in the arm and

More information

EVALUATION OF NONINVASIVE PULSE TRANSIT TIME METHODOLOGIES FOR DIAGNOSIS OF HYPERTENSION DANIEL JOHN BADGER. A thesis submitted to the

EVALUATION OF NONINVASIVE PULSE TRANSIT TIME METHODOLOGIES FOR DIAGNOSIS OF HYPERTENSION DANIEL JOHN BADGER. A thesis submitted to the EVALUATION OF NONINVASIVE PULSE TRANSIT TIME METHODOLOGIES FOR DIAGNOSIS OF HYPERTENSION by DANIEL JOHN BADGER A thesis submitted to the Graduate School-New Brunswick Rutgers, The State University of New

More information

ASSeSSing the risk of fatal cardiovascular disease

ASSeSSing the risk of fatal cardiovascular disease ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril

More information

Selected age-associated changes in the cardiovascular system

Selected age-associated changes in the cardiovascular system Selected age-associated changes in the cardiovascular system Tamara Harris, M.D., M.S. Chief, Interdisciplinary Studies of Aging Acting Co-Chief, Laboratory of Epidemiology and Population Sciences Intramural

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

37 1 The Circulatory System

37 1 The Circulatory System H T H E E A R T 37 1 The Circulatory System The circulatory system and respiratory system work together to supply cells with the nutrients and oxygen they need to stay alive. a) The respiratory system:

More information

Section 03: Pre Exercise Evaluations and Risk Factor Assessment

Section 03: Pre Exercise Evaluations and Risk Factor Assessment Section 03: Pre Exercise Evaluations and Risk Factor Assessment ACSM Guidelines: Chapter 3 Pre Exercise Evaluations ACSM Manual: Chapter 3 Risk Factor Assessments HPHE 4450 Dr. Cheatham Purpose The extent

More information

Ultimate Solution. for Healthy Life. HANBYUL Overview

Ultimate Solution. for Healthy Life. HANBYUL Overview Ultimate Solution for Healthy Life 1. SP-S2 / SP-S3 (electronic stethoscope) 2. PP-2000 (diagnosis system for atherosclerosis) 3. GAON21A (diagnosis system for cardiac function) 4. ER-1000 (single channel

More information

AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE

AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE Good for your patients. Good for your practice. Using the AngioDefender system to complement your patients care routine enables you to: Improve your patient

More information

Clinical usefulness of the second peak of radial systolic blood pressure for estimation of aortic systolic blood pressure

Clinical usefulness of the second peak of radial systolic blood pressure for estimation of aortic systolic blood pressure (2009) 23, 538 545 & 2009 Macmillan Publishers Limited All rights reserved 0950-9240/09 $32.00 www.nature.com/jhh ORIGINAL ARTICLE Clinical usefulness of the second peak of radial systolic blood pressure

More information

Study IV: 2000mg Single Dose

Study IV: 2000mg Single Dose Project Report Evaluation of Cardiovascular and Pharmacodynamic effects of Terminalia arjuna with special reference to arterial stiffness and endothelial function in healthy human male subjects Study IV:

More information